Evidence map›Paper›PMID 26244863›Full record

ArticlePloS one2015

A Three-Tiered Study of Differences in Murine Intrahost Immune Response to Multiple Pneumococcal Strains.

Ericka Mochan-Keef, David Swigon, G Bard Ermentrout, Gilles Clermont

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ericka Mochan-KeefJoint Carnegie Mellon University-University of Pittsburgh PhD Program in Computational Biology, Pittsburgh, PA, United States of America.
David SwigonDepartment of Mathematics, University of Pittsburgh, Pittsburgh, PA, United States of America.
G Bard ErmentroutDepartment of Mathematics, University of Pittsburgh, Pittsburgh, PA, United States of America.
Gilles ClermontDepartment of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, United States of America; McGowan Institute for Regenerative Medicine, Center for Inflammation and Regenerative Modeling, University of Pittsburgh, Pittsburgh, PA, United States of America.
University of Pittsburgh · US

Funding

Training, Outreach & Diversity ComponentU54GM088491 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI LAKOSKI, JOAN M · 2009 to 2018
$16.7M
Model-Based Decisions in SepsisR01GM105728 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CLERMONT, GILLES · 2014 to 2017
$1.1M
Predictive Biosignatures for Complicated Novel H1N1 InfluenzaR56AI093930 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CLERMONT, GILLES, ROSS, TED M · 2012 to 2012
$720k
NIAID NIH HHS R56 AI093930NIAID NIH HHS R56AI093930NIGMS NIH HHS R01 GM105728NIGMS NIH HHS R01GM105728NIGMS NIH HHS U54 GM088491NIGMS NIH HHS U54GM088491
6 · The paper itself

Abstract

We apply a previously developed 4-variable ordinary differential equation model of in-host immune response to pneumococcal pneumonia to study the variability of the immune response of MF1 mice and to explore bacteria-driven differences in disease progression and outcome. In particular, we study the immune response to D39 strain of bacteria missing portions of the pneumolysin protein controlling either the hemolytic activity or complement-activating activity, the response to D39 bacteria deficient in either neuraminidase A or B, and the differences in the response to D39 (serotype 2), 0100993 (serotype 3), and TIGR4 (serotype 4) bacteria. The model accurately reproduces infection kinetics in all cases and provides information about which mechanisms in the immune response have the greatest effect in each case. Results suggest that differences in the ability of bacteria to defeat immune response are primarily due to the ability of the bacteria to elude nonspecific clearance in the lung tissue as well as the ability to create damage to the lung epithelium.

Indexed as

AlgorithmsModels, ImmunologicalAnimalsBacterial ProteinsHost-Pathogen InteractionsIsoenzymesLungMice, Inbred BALB CMice, Inbred C57BLMice, Inbred CBANeuraminidasePneumonia, PneumococcalSerotypingSpecies SpecificityStreptococcus pneumoniaeStreptolysinsBacterial ProteinsIsoenzymesNeuraminidaseplY protein, Streptococcus pneumoniaeStreptolysins

Identifiers

PMID26244863
PMCPMC4526468
OpenAlexW1960906466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.